Viewing Study NCT00368134


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2025-12-30 @ 9:12 AM
Study NCT ID: NCT00368134
Status: COMPLETED
Last Update Posted: 2007-06-28
First Post: 2006-08-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module